These findings provide a substantial contribution to the already compelling evidence that plasma PAI-1 is an important clinical predictor of vascular stiffness, hypertension, and diastolic dysfunction, especially in individuals with obesity and diabetes. This evidence concerns the gene SERPINE1 and Hypertension.